Annual Accounts Receivable
$20.28 M
+$9.32 M+85.11%
December 31, 2023
Summary
- As of February 7, 2025, RXST annual accounts receivable is $20.28 million, with the most recent change of +$9.32 million (+85.11%) on December 31, 2023.
- During the last 3 years, RXST annual accounts receivable has risen by +$17.42 million (+607.89%).
- RXST annual accounts receivable is now at all-time high.
Performance
RXST Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$25.37 M
-$355.00 K-1.38%
September 30, 2024
Summary
- As of February 7, 2025, RXST quarterly accounts receivable is $25.37 million, with the most recent change of -$355.00 thousand (-1.38%) on September 30, 2024.
- Over the past year, RXST quarterly accounts receivable has increased by +$5.09 million (+25.08%).
- RXST quarterly accounts receivable is now -1.38% below its all-time high of $25.72 million, reached on June 30, 2024.
Performance
RXST Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RXST Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +85.1% | +25.1% |
| 3 y3 years | +607.9% | +25.1% |
| 5 y5 years | +2470.5% | +25.1% |
RXST Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +317.1% | -1.4% | +421.8% |
| 5 y | 5-year | at high | +2470.5% | -1.4% | +1019.5% |
| alltime | all time | at high | +2470.5% | -1.4% | +1019.5% |
RxSight Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.37 M(-1.4%) |
| Jun 2024 | - | $25.72 M(+19.4%) |
| Mar 2024 | - | $21.55 M(+6.3%) |
| Dec 2023 | $20.28 M(+85.1%) | $20.28 M(+33.0%) |
| Sep 2023 | - | $15.24 M(+14.7%) |
| Jun 2023 | - | $13.29 M(+4.9%) |
| Mar 2023 | - | $12.67 M(+15.6%) |
| Dec 2022 | $10.96 M | $10.96 M(+21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $9.02 M(+31.0%) |
| Jun 2022 | - | $6.88 M(+22.4%) |
| Mar 2022 | - | $5.63 M(+15.7%) |
| Dec 2021 | $4.86 M(+69.7%) | $4.86 M(+11.6%) |
| Sep 2021 | - | $4.36 M(+10.7%) |
| Jun 2021 | - | $3.94 M(+73.7%) |
| Mar 2021 | - | $2.27 M(-20.9%) |
| Dec 2020 | $2.87 M(+263.1%) | $2.87 M |
| Dec 2019 | $789.00 K | - |
FAQ
- What is RxSight annual accounts receivable?
- What is the all time high annual accounts receivable for RxSight?
- What is RxSight annual accounts receivable year-on-year change?
- What is RxSight quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for RxSight?
- What is RxSight quarterly accounts receivable year-on-year change?
What is RxSight annual accounts receivable?
The current annual accounts receivable of RXST is $20.28 M
What is the all time high annual accounts receivable for RxSight?
RxSight all-time high annual accounts receivable is $20.28 M
What is RxSight annual accounts receivable year-on-year change?
Over the past year, RXST annual accounts receivable has changed by +$9.32 M (+85.11%)
What is RxSight quarterly accounts receivable?
The current quarterly accounts receivable of RXST is $25.37 M
What is the all time high quarterly accounts receivable for RxSight?
RxSight all-time high quarterly accounts receivable is $25.72 M
What is RxSight quarterly accounts receivable year-on-year change?
Over the past year, RXST quarterly accounts receivable has changed by +$5.09 M (+25.08%)